Quo Vadis With Targeted Drugs in the 21st Century?

被引：38

作者：

Bergh, Jonas ^{[1
]}

机构：

[1] Karolinska Inst & Univ Hosp, Stockholm, Sweden

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 01期

关键词：

GENE-EXPRESSION PROFILES; METASTATIC BREAST-CANCER; ESTROGEN-RECEPTORS; HER-2; STATUS; CHEMOTHERAPY; EFFICACY; AMPLIFICATION; POLYMORPHISM; CARCINOMAS; WOMEN;

D O I：

10.1200/JCO.2008.18.8342

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2 / 5

页数：4

共 34 条

[1]

Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0

[2] An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors [J].

Amador, ML ;

Oppenheimer, D ;

Perea, S ;

Maitra, A ;

Cusati, G ;

Iacobuzio-Donahue, C ;

Baker, SD ;

Ashfaq, R ;

Takimoto, C ;

Forastiere, A ;

Hidalgo, M .

CANCER RESEARCH, 2004, 64 (24) :9139-9143

[3] RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial (Retracted Article. See vol 12, pg 116, 2011) [J].

不详 .

LANCET ONCOLOGY, 2007, 8 (12) :1071-1078

[4] Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients [J].

Etienne-Grimaldi, MC ;

Pereira, S ;

Magné, N ;

Formento, JL ;

Francoual, M ;

Fontana, X ;

Demard, F ;

Dassonville, O ;

Poissonnet, G ;

Santini, J ;

Bensadoun, RJ ;

Szepetowski, P ;

Milano, G .

ANNALS OF ONCOLOGY, 2005, 16 (06) :934-941

[5]

European Medicines Agency, GUID EV ANT MED PROD

[6]

Franco A, 2004, J CLIN ONCOL, V22, p12S

[7] Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites [J].

Gancberg, D ;

Di Leo, A ;

Cardoso, F ;

Rouas, G ;

Pedrocchi, M ;

Paesmans, M ;

Verhest, A ;

Bernard-Marty, C ;

Piccart, MJ ;

Larsimont, D .

ANNALS OF ONCOLOGY, 2002, 13 (07) :1036-1043

[8] Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer [J].

Gianni, L ;

Zambetti, M ;

Clark, K ;

Baker, J ;

Cronin, M ;

Wu, J ;

Mariani, G ;

Rodriguez, J ;

Carcangiu, M ;

Watson, D ;

Valagussa, P ;

Rouzier, R ;

Symmans, WF ;

Ross, JS ;

Hortobagyi, GN ;

Pusztai, L ;

Shak, S .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (29) :7265-7277

[9] Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes [J].

Goetz, MP ;

Rae, JM ;

Suman, VJ ;

Safgren, SL ;

Ames, MM ;

Visscher, DW ;

Reynolds, C ;

Couch, FJ ;

Lingle, WL ;

Flockhart, DA ;

Desta, Z ;

Perez, EA ;

Ingle, JN .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9312-9318

[10] THE RELATIONSHIP BETWEEN ESTROGEN-RECEPTORS IN PRIMARY AND SECONDARY BREAST CARCINOMAS AND IN SEQUENTIAL PRIMARY BREAST CARCINOMAS [J].

HAHNEL, R ;

TWADDLE, E .

BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (02) :155-163

← 1 2 3 4 →